CRIS Current Research Information System

ROBUSTELLI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.022
EU - Europa 1.616
AS - Asia 871
AF - Africa 142
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
SA - Sud America 4
Totale 4.663
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.016
GB - Regno Unito 461
VN - Vietnam 371
SE - Svezia 278
IT - Italia 269
CN - Cina 195
DE - Germania 194
SG - Singapore 134
IN - India 105
IE - Irlanda 74
CH - Svizzera 67
FR - Francia 65
TG - Togo 50
RU - Federazione Russa 45
ZA - Sudafrica 37
BG - Bulgaria 36
EE - Estonia 35
JO - Giordania 29
CI - Costa d'Avorio 28
NG - Nigeria 27
UA - Ucraina 23
BE - Belgio 22
FI - Finlandia 16
JP - Giappone 10
GR - Grecia 8
IR - Iran 8
UZ - Uzbekistan 7
CA - Canada 6
NL - Olanda 6
PL - Polonia 4
AU - Australia 3
EU - Europa 3
AT - Austria 2
BD - Bangladesh 2
BR - Brasile 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
LT - Lituania 2
LV - Lettonia 2
MK - Macedonia 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
CL - Cile 1
HR - Croazia 1
IL - Israele 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
Totale 4.663
Salva come PNG Salva come JPEG
Città #
Southend 436
Chandler 328
Dong Ket 235
Ashburn 170
Fairfield 164
Ann Arbor 118
Houston 111
Singapore 108
Woodbridge 98
Wilmington 86
Princeton 84
Seattle 78
Dublin 74
Cambridge 64
Bern 58
Beijing 51
Bologna 50
Lomé 50
Nanjing 38
Westminster 38
Sofia 36
Padova 34
Medford 33
Amman 29
New York 29
Abidjan 28
Abeokuta 27
Bremen 27
Berlin 23
Boardman 23
Redmond 23
Brussels 21
Santa Clara 20
Redwood City 18
Helsinki 16
Saint Petersburg 15
Paris 14
Rome 14
Nanchang 13
Jinan 12
Milan 12
Shenyang 12
Hebei 11
Mountain View 11
Florence 10
Changsha 9
Falls Church 9
San Diego 8
Turin 8
Los Angeles 7
Monmouth Junction 7
Norwalk 7
Augusta 6
Leawood 6
Pune 6
Tokyo 6
Andover 5
Athens 5
Forlì 5
Hangzhou 5
Hyderabad 5
Jiaxing 5
Tianjin 5
Des Moines 4
Fremont 4
Guangzhou 4
Busseto 3
Bühl 3
Castel Madama 3
Catania 3
Dearborn 3
Dehradun 3
Haikou 3
Henderson 3
Kolkata 3
London 3
Reggio Emilia 3
Taiyuan 3
Torino 3
Vellore 3
Zhengzhou 3
Alpharetta 2
Avellino 2
Bay Shore 2
Bitola 2
Castelfranco Emilia 2
Ceska 2
Chesterfield 2
Den Haag 2
Dhaka 2
Frankfurt Am Main 2
Groningen 2
Kiev 2
Kilburn 2
Latina 2
Lausanne 2
Malvern 2
Miradolo Terme 2
Olalla 2
Phoenix 2
Totale 3.159
Salva come PNG Salva come JPEG
Nome #
Adult "Triple Negative" ACUTE Lymphoblastic Leukemia Genome Wide Characterization 224
Blinatumomab Is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: The Bologna Compassionate Program Experience 184
Adult B-Cell Precursor Acute Lymphoblastic Leukemia (BC-ALL) Negative For Recurrent Fusion Genes Are Characterized By a High Complex Genetic Heterogeneity Influencing Prognosis 183
Alterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 181
The alteration in key regulator genes of autophagy is mainstream mechanism of therapy resistance and impact prognosis of acute myelogenous leukemia (AML): results from diagnosis genomic analysis on 148 consecutive patients treated with intensive chemotherapy and long-term survival follow-up 174
Novel and rare fusion transcripts involving transcription factors and tumor suppressor genes in acute myeloid leukemia 157
Clustering Adult ACUTE Lymphoblastic Leukemia (ALL) Philadelphia Negative (Ph-) By Whole Exome Sequencing (WES) Analysis 150
First Report of the Gimema LAL1811 Phase II Prospective Study of the Combination of Steroids with Ponatinib As Frontline Therapy of Elderly or Unfit Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia 137
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia 136
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia 131
Copy number variants signature in two patients with relapsed acute promyelocytic leukemia 127
Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients 125
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia 125
Deficient necroptosis pathway as a negative prognostic factor in acute myeloid leukemia. 123
DEEP MOLECULAR CHARACTERIZATION OF ADULT B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BC-ALL) NEGATIVE FOR RECURRENT FUSION GENES REVEALS A HIGH COMPLEX GENETIC HETEROGENEITY INFLUENCING PROGNOSIS 121
Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome 118
Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia 118
Survival analysis of patients carrying different FLT3 mutations (internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations) in 459 consecutive non M3 newly diagnosed acute myeloid leukemia (AML) 115
Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia 110
COMPLEX GENETIC HETEROGENEITY INFLUENCES PROGNOSIS IN ADULT B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA NEGATIVE FOR RECURRENT FUSION GENES 109
Microarray analysis to identifiy novel copy number alterations in acute myeloid leukemia 109
RNA Sequencing Reveals Novel and Rare Fusion Transcripts in Acute Myeloid Leukemia 106
MHC-I Antigen Presentation Role in Immune Escape of Acute Myeloid Leukemia with High Burden of Genomic Aberration 102
Enhance the Efficacy of Doxorubicin Destabilizing the G2/M Checkpoint with a CHK1/CHK2 Inhibitor Pre-Treatment on Acute Lymphoblastic Leukemia 102
The synergistic efficacy of Chk1/Chk2 inhibitors and doxorubicin in the treatment of acute lymphoblastic leukemia 102
The Inhibition of Checkpoint Kinase 1 As a Promising Strategy to Increase the Effectiveness of Different Treatments in Acute Lymphoblastic Leukemia 101
Ponatinib Is Well Tolerated and Active In Patients With Relapsed/Refractory Philadelphia Positive Acute Lymphoblastic Leukemia (PH+ ALL) and Advanced Phase Of Chronic Myelogenous Leukemia (CML) Harbouring T315I Mutation: The Bologna Experience 100
Prognostic significance of alterations of pathways regulating autophagy in acute myeloid leukemia 97
Tp53 mutation screening in adult acute myeloid leukemia (AML) patients shows a strong association with complex karyotype and poor outcome 91
DEREGULATED EXPRESSION OF CHECKPOINT KINASE 1 (CHK1) IN BCR-ABL-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (BCR-ABL+ ALL) SUGGESTS A NEW THERAPEUTIC TARGET 89
Novel fusion transcripts identified by RNAseq cooperate with somatic mutations in the pathogenesis of acute myeloid leukemia 89
Override the doxorubicin-induced G2/M checkpoint using cell-cycle checkpoint inhibitors on acute lymphoblastic leukemia 87
You have accessAlterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 87
Leukemia Associated TP53 Mutations in AML Patients ARE Strongly Associated with Complex Karyotype and Poor Outcome 87
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 87
Ponatinib is well tolerated and active in patients with relapsed/refractory philadelphia positive leukemias: The Bologna experience 82
Very poor outcome and chemoresistance of acute myeloid leukemia patients with TP53 mutations: Correlation with complex karyotype and clinical outcome 80
You have accessMine the Stability of the G2/M Checkpoint to Break Down Acute Lymphoblastic Leukemia Defenses Against Antineoplastic Drugs 77
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant 68
Synergism through WEE1 and CHK1 inhibition in acute lymphoblastic leukemia 66
INCB84344-201: Ponatinib and steroids in frontline therapy of unfit patients with Ph+ acute lymphoblastic leukemia 53
Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid Leukemia 51
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment 40
Totale 4.801
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.209
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.209
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020662 0 0 0 42 80 57 91 108 108 82 65 29
2020/2021798 96 76 36 8 24 31 7 45 63 16 45 351
2021/2022970 123 24 44 90 95 43 13 66 36 61 194 181
2022/20231.207 128 166 62 163 108 92 29 54 200 34 80 91
2023/2024327 10 38 22 37 24 82 19 42 12 11 10 20
2024/2025232 45 164 23 0 0 0 0 0 0 0 0 0
Totale 4.801